Discontinuation report MYLAN-GABAPENTIN

Last updated on 2017-09-08 History
Report ID 20169
Drug Identification Number 02397471
Brand name MYLAN-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-08-23
Remaining supply date 2016-10-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-09-08 French Compare
v4 2017-09-08 English Compare
v3 2017-08-24 French Compare
v2 2017-08-24 English Compare
v1 2017-08-24 English Compare

Showing 1 to 5 of 5